My relationship with Dana-Farber began 26 years ago, when I joined the board at the encouragement of Steve Kay. I was the youngest board member at the time, and was attracted to the importance of the mission, along with the dual focus on cutting-edge research and direct patient care. While fortunate so far to have only modest incidence of cancer in my own family, progress here is truly the next frontier, not only for those with an unfair immediate need, but for all of us, as lifespans hopefully continue to extend due to the remarkable success with other health issues.
While scientific breakthroughs and knowledge creation are the key to future success, Dana-Farber is truly unique and special with its emphasis on the human aspects of patient care. This deeply caring mindset has only grown with the success and size of the organization. I am proud and grateful for the opportunity to continue to lead, serve and support Dana-Farber. Moving from Boston to NYC in 1998, I am a bit farther from the buildings but still equally close to the mission.